Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Graf, Robin Dr. (2) Hinz, Michael Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kocks, Christine Dr. (1) Leutz, Achim Prof. Dr. (1) Mertins, Philipp Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (3) Wollert-Wulf, Brigitte (1) (-) Janz, Martin Dr. (6) (-) Mathas, Stephan Dr. (12) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (16) Entwicklung Mechanismus-basierter Krebstherapien (2) Genomdiversifikation & Integrität (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Immunologie und Gentherapie (9) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Tumorimmunologie (1) 1999 (1) 2000 (1) 2001 (1) (-) 2002 (5) 2003 (3) 2004 (3) 2005 (3) 2006 (5) 2007 (4) 2008 (4) 2009 (4) 2010 (3) 2011 (4) 2012 (2) 2013 (3) 2014 (2) (-) 2015 (5) 2016 (3) 2017 (5) 2018 (1) 2019 (2) (-) 2020 (6) 2021 (3) 2022 (7) 2023 (10) 2024 (2) 16 Ergebnisse: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Biologie maligner Lymphome200220152020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz 01. Juni 2020 / JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert 06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado 05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio 01. Juni 2015 / Front Biosci The origins of ALK translocations V. Roukos S. Mathas 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz
01. Juni 2020 / JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert
06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado
05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou